WHITEFISH, MT / ACCESSWIRE / March 31, 2014 / TDM Financial, a leading financial network covering new, emerging and established companies across many different industry verticals, today announced that Medican Enterprises, Inc. (OTCBB: MDCN) has engaged its services. Medican Enterprises is a biopharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market.
“We are committed to transparently building a diverse and balanced shareholder base,” said Medican Enterprises Inc. CEO Ken Williams. “TDM Financial enables us to enhance communications with individual and institutional investors interested in the medical marijuana space through fully-compliant and high-quality coverage on mainstream and industry-specific financial websites.”
Medican Enterprises, Inc.’s wholly owned subsidiary Medican Systems, Inc. is an industry leader in the design, construction and operation of Medical Marijuana and Cultivation Centers across Canada. Medican Enterprises drives shareholder value through its scalable business model and commitment to scientific research, operational excellence and regulatory compliance.
“The U.S. market for legal marijuana is expected to grow from $2.3 billion in 2014 to $10.2 billion over the next five years according to ArcView Market Research,” said TDM Financial President Daniel Minton. “We are excited to be working with Medican Enterprises as it aims to become a leading medical marijuana supplier through joint venture partnerships and its unique team.”
About TDM Financial:
TDM Financial is a dedicated financial networking covering new, emerging and established companies across many different industry verticals. Its flagship property, SECFilings.com, is a leading destination for sophisticated investors looking to track and analyze regulatory filings with the SEC with over 600,000 registered members receiving real-time e-mail alerts on companies they follow.
Learn more at http://www.tdmfinancial.com/ or by calling (877) 225-0326.About Medican Enterprises, Inc.
Medican Enterprises is a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market. It’s wholly owned subsidiary Medican Systems, Inc. is an industry leader in the design, construction and operation of Medical Marijuana and Cultivation Centers across Canada. Traded on the OTCBB, Medican drives shareholder value through its scalable business model and commitment to scientific research, operational excellence and regulatory compliance. For more information visit: http://www.medicaninc.com/.Forward-Looking and Cautionary Statements:
Certain statements contained herein contain “forward-looking statements” within the meaning of Section 27A of Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medican Enterprises Inc. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Medican Enterprises Inc. disclaims any obligation to update or to announce publicly the results of any revision of the forward-looking statements contained or incorporated by reference herein to reflect future events or developments. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at http://www.sec.gov/.